CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Vancomycin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 20 USDMF, 16 CEP/COS, 8 JDMF, 2 EU WC, 14 KDMF, 20 NDC API, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

332 FDF Dossiers, 145 FDA Orange Book, 76 Europe, 30 Canada, 12 Australia, 15 South Africa, 54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL, CAPSULE;ORAL - EQ 125MG BASE, CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

7 DKSH, 1 Faran Shimi Pharmaceutical, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 6 Actylis, 14 BASF, 2 Finar, 2 Gangwal Chemicals, 3 Lonza Capsugel, 2 Nomisma Healthcare, 1 Pluviaendo, 1 Qualicaps, 6 Roquette, 1 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 8 Empty Capsules, 6 Parenteral, 6 Film Formers & Plasticizers, 6 Fillers, Diluents & Binders, 6 Solubilizers, 5 Controlled & Modified Release, 4 Granulation, 3 Lubricants & Glidants, 3 Coloring Agents, 3 Taste Masking, 1 Surfactant & Foaming Agents, 1 Direct Compression, 1 Emulsifying Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 95 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 69 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

43 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

67 US Patents

67 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 4 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/03/2025	Lek Pharmaceuticals	Slovenia	Lek Pharmaceuticals d. d.	217MF10740	Vancomycin hydrochloride	2005-10-07	2007-01-22	Verovskova 57, SI-1526 Ljubljana, Slovenia
28/03/2025	Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.	China	Livzon Group Fuzhou Fuxing Pharmaceutical Co. , Ltd.	304MF10074	Vancomycin Hydrochloride	2022-05-18	2022-05-18	No. 8 Nangang Road, Jiangyin Industrial Concentration Zone, Fuqing, Fuzhou City, Fujian Province, P. R. China 350309

Vancomycin Hydrochloride

Vancomycin Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

63 API Suppliers

20 USDMF

16 CEP/COS

8 JDMF

2 EU WC

14 KDMF

20 NDC API

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

332 FDF Dossiers

145 FDA Orange Book

76 Europe

30 Canada

12 Australia

15 South Africa

54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL

CAPSULE;ORAL - EQ 125MG BASE

CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

7 DKSH

1 Faran Shimi Pharmaceutical

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

6 Actylis

14 BASF

2 Finar

2 Gangwal Chemicals

3 Lonza Capsugel

2 Nomisma Healthcare

1 Pluviaendo

1 Qualicaps

6 Roquette

1 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical

9 Coating Systems & Additives

9 Thickeners and Stabilizers

8 Empty Capsules

6 Parenteral

6 Film Formers & Plasticizers

6 Fillers, Diluents & Binders

6 Solubilizers

5 Controlled & Modified Release

4 Granulation

3 Lubricants & Glidants

3 Coloring Agents

3 Taste Masking

1 Surfactant & Foaming Agents

1 Direct Compression

1 Emulsifying Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

95 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

69 Regulatory FDF Prices

2 Annual Reports

MARKET PLACE

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons